| SRPT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SRPT shares outstanding history going back to 7/12/2012:
Also see: SRPT Market Cap History SRPT YTD Return |
SRPT Shares Outstanding History — Sarepta Therapeutics Share Count Over Time
As of 5/1/2026 Sarepta Therapeutics has 105.58 million SRPT shares outstanding. Investors often track the SRPT shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows SRPT share count trends over time, with 56 historical shares outstanding datapoints presented, dating back to 7/12/2012.
| SRPT Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SRPT Historical Shares Outstanding: +11.80% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SRPT Stock Price Chart |
| About Sarepta Therapeutics Inc |
| Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. Co. is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It has developed multiple approved products for the treatment of Duchenne muscular dystrophy (Duchenne) and is developing potential therapeutic candidates for a range of diseases and disorders, including Duchenne, Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders. We show 56 historical shares outstanding datapoints in our coverage of SRPT's shares outstanding history. Understanding the changing numbers of SRPT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SRPT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SRPT by allowing them to research SRPT shares outstanding history as well as any other stock in our coverage universe. |
| SRPT Current Stock Quote |
Quotes delayed 20 minutes  Free SRPT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| SRPT Share Performance |
| Shares Outstanding Peers |
| Sarepta Therapeutics (SRPT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
SRRA Shares Outstanding History SRRK Shares Outstanding History SRTS Shares Outstanding History SRZN Shares Outstanding History SSII Shares Outstanding History SSKN Shares Outstanding History STAA Shares Outstanding History STAB Shares Outstanding History STE Shares Outstanding History STEX Shares Outstanding History More Healthcare companies » |
SRPT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
